Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of British Columbia

$58,655.00

A spectrochemical imaging system for rapid and nondisruptive screening for pluripotency and differentiation in cultures of embryonic stem cells

EF 2008-09

Résumé
Embryonic stem cells (ESC) offer tremendous potential for addressing a host of important biomedical problems, both in clinical and laboratory settings. This potential has generated extraordinary excitement over the use of these cells to devise novel cellular therapies for many currently debilitating and costly human diseases (e.g., diabetes and Parkinson's disease), as well as irreparable injuries (e.g., spinal cord paralysis). There are, however, many hurdles to overcome between our present state and new therapeutic applications. One of the fundamental technological obstacles that dramatically slows progress in this area is the lack of rapid, nondestructive assays for distinguishing ESC from other (differentiated) cells within a growing culture. We are proposing to develop such a rapid, nondestructive, non-contact screening methodology based on an optical technique called coherent anti-Stokes Raman scattering (CARS) microscopy. This nonlinear optical method permits imaging of ESCs in situ within a culture and exploits the rich chemical information carried by the CARS signal to distinguish stem cells from differentiating cells. Specifically, we are proposing i) to develop a robust optical component system for efficient exposure and collection of CARS spectra and advanced signal-processing methods to aid the interpretation of CARS spectra of ESC; ii) to undertake the first spectrochemical imaging investigation involving human ESC to identify and characterize the spectral features most sensitive to cellular changes (and/or the rate of such changes) accompanying differentiation; iii) to prepare this technology for installation at an existing bioimaging core facility that provides access by stem cell biologists and other medical scientists. This project will lay the foundation for accelerated progress toward developing human embryonic stem cell-based therapies and will facilitate the broader use of these cells to identify new drugs that stimulate or repress particular regenerative events in vivo.
Programme
Collaborative Health Research Projects
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
351353-2008
Name nom
Turner, Robin
Department département
Michael Smith Laboratories
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
58655
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
3
Application title
A spectrochemical imaging system for rapid and nondisruptive screening for pluripotency and differentiation in cultures of embryonic stem cells
Keyword
NA
Application summary
Embryonic stem cells (ESC) offer tremendous potential for addressing a host of important biomedical problems, both in clinical and laboratory settings. This potential has generated extraordinary excitement over the use of these cells to devise novel cellular therapies for many currently debilitating and costly human diseases (e.g., diabetes and Parkinson's disease), as well as irreparable injuries (e.g., spinal cord paralysis). There are, however, many hurdles to overcome between our present state and new therapeutic applications. One of the fundamental technological obstacles that dramatically slows progress in this area is the lack of rapid, nondestructive assays for distinguishing ESC from other (differentiated) cells within a growing culture. We are proposing to develop such a rapid, nondestructive, non-contact screening methodology based on an optical technique called coherent anti-Stokes Raman scattering (CARS) microscopy. This nonlinear optical method permits imaging of ESCs in situ within a culture and exploits the rich chemical information carried by the CARS signal to distinguish stem cells from differentiating cells. Specifically, we are proposing i) to develop a robust optical component system for efficient exposure and collection of CARS spectra and advanced signal-processing methods to aid the interpretation of CARS spectra of ESC; ii) to undertake the first spectrochemical imaging investigation involving human ESC to identify and characterize the spectral features most sensitive to cellular changes (and/or the rate of such changes) accompanying differentiation; iii) to prepare this technology for installation at an existing bioimaging core facility that provides access by stem cell biologists and other medical scientists. This project will lay the foundation for accelerated progress toward developing human embryonic stem cell-based therapies and will facilitate the broader use of these cells to identify new drugs that stimulate or repress particular regenerative events in vivo.